Zhang Q, Xu Z, Han R, Wang Y, Ye Z, Zhu J
Nat Commun. 2024; 15(1):8338.
PMID: 39333076
PMC: 11436687.
DOI: 10.1038/s41467-024-52285-7.
You Z, Masai H
Biology (Basel). 2024; 13(8).
PMID: 39194567
PMC: 11351656.
DOI: 10.3390/biology13080629.
Branzei D, Bene S, Gangwani L, Szakal B
DNA Repair (Amst). 2024; 142:103742.
PMID: 39137555
PMC: 11425796.
DOI: 10.1016/j.dnarep.2024.103742.
Yanez-Vilches A, Romero A, Barrientos-Moreno M, Cruz E, Gonzalez-Prieto R, Sharma S
PLoS Genet. 2024; 20(5):e1011148.
PMID: 38776358
PMC: 11149843.
DOI: 10.1371/journal.pgen.1011148.
McFaline-Figueroa J, Srivatsan S, Hill A, Gasperini M, Jackson D, Saunders L
Cell Genom. 2024; 4(2):100487.
PMID: 38278156
PMC: 10879025.
DOI: 10.1016/j.xgen.2023.100487.
The structural mechanism of dimeric DONSON in replicative helicase activation.
Cvetkovic M, Passaretti P, Butryn A, Reynolds-Winczura A, Kingsley G, Skagia A
Mol Cell. 2023; 83(22):4017-4031.e9.
PMID: 37820732
PMC: 7616792.
DOI: 10.1016/j.molcel.2023.09.029.
Synergism between CMG helicase and leading strand DNA polymerase at replication fork.
Xu Z, Feng J, Yu D, Huo Y, Ma X, Lam W
Nat Commun. 2023; 14(1):5849.
PMID: 37730685
PMC: 10511561.
DOI: 10.1038/s41467-023-41506-0.
Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Inhibitor, in Patients with Advanced Solid Tumors: A Phase I First-in-Human Study.
Kuboki Y, Shimizu T, Yonemori K, Kojima T, Kondo S, Koganemaru S
Cancer Res Commun. 2023; 2(11):1426-1435.
PMID: 36970056
PMC: 10035389.
DOI: 10.1158/2767-9764.CRC-22-0277.
Short-term molecular consequences of chromosome mis-segregation for genome stability.
Garribba L, De Feudis G, Martis V, Galli M, Dumont M, Eliezer Y
Nat Commun. 2023; 14(1):1353.
PMID: 36906648
PMC: 10008630.
DOI: 10.1038/s41467-023-37095-7.
Analysis of the expression and prognostic significance of DDK complex in Hepatocarcinoma.
Wang M, Qiu Z, Wang Y, Lian B, Bai J, Zhou Y
BMC Cancer. 2023; 23(1):19.
PMID: 36609254
PMC: 9817372.
DOI: 10.1186/s12885-022-10475-w.
Snapshot imprinting as a tool for surface mapping and identification of novel biomarkers of senescent cells.
Piletska E, Thompson D, Jones R, Cruz A, Poblocka M, Canfarotta F
Nanoscale Adv. 2022; 4(24):5304-5311.
PMID: 36540121
PMC: 9724690.
DOI: 10.1039/d2na00424k.
The CMG helicase and cancer: a tumor "engine" and weakness with missing mutations.
Xiang S, Reed D, Alexandrow M
Oncogene. 2022; 42(7):473-490.
PMID: 36522488
PMC: 9948756.
DOI: 10.1038/s41388-022-02572-8.
Crosstalk between Thyroid Hormone and Corticosteroid Signaling Targets Cell Proliferation in Tadpole Liver.
Rigolet M, Buisine N, Scharwatt M, Duvernois-Berthet E, Buchholz D, Sachs L
Int J Mol Sci. 2022; 23(22).
PMID: 36430192
PMC: 9692397.
DOI: 10.3390/ijms232213715.
Use of Nuclear and Chromatin Enrichment Procedures for Quantitation of Yeast DNA Replication Proteins Using SILAC.
Kubota T
Methods Mol Biol. 2022; 2603:209-218.
PMID: 36370282
DOI: 10.1007/978-1-0716-2863-8_17.
WEE1 inhibition augments CDC7 (DDK) inhibitor-induced cell death in Ewing sarcoma by forcing premature mitotic entry and mitotic catastrophe.
Martin J, Sims J, Gupta A, Bakin A, Ohm J
Cancer Res Commun. 2022; 2(6):471-482.
PMID: 36338546
PMC: 9635308.
DOI: 10.1158/2767-9764.crc-22-0130.
Cryo-EM structure of human hexameric MCM2-7 complex.
Xu N, Lin Q, Tian H, Liu C, Wang P, Suen C
iScience. 2022; 25(9):104976.
PMID: 36117988
PMC: 9475327.
DOI: 10.1016/j.isci.2022.104976.
Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway.
Pauzaite T, Tollitt J, Sopaci B, Caprani L, Iwanowytsch O, Thacker U
Biomedicines. 2022; 10(8).
PMID: 36009559
PMC: 9405858.
DOI: 10.3390/biomedicines10082012.
CDC7 as a novel biomarker and druggable target in cancer.
Liu R, Huang Y
Clin Transl Oncol. 2022; 24(10):1856-1864.
PMID: 35657477
DOI: 10.1007/s12094-022-02853-4.
The structural basis of Cdc7-Dbf4 kinase dependent targeting and phosphorylation of the MCM2-7 double hexamer.
Saleh A, Noguchi Y, Aramayo R, Ivanova M, Stevens K, Montoya A
Nat Commun. 2022; 13(1):2915.
PMID: 35614055
PMC: 9133112.
DOI: 10.1038/s41467-022-30576-1.
Structural Insight into the MCM double hexamer activation by Dbf4-Cdc7 kinase.
Cheng J, Li N, Huo Y, Dang S, Tye B, Gao N
Nat Commun. 2022; 13(1):1396.
PMID: 35296675
PMC: 8927117.
DOI: 10.1038/s41467-022-29070-5.